Enhanced Prediction of HER2 Status in Breast Cancer through the Integration of Intratumoral and Peritumoral Radiomic Features from DCE-MRI - Top-Institutions - MDSpire

Enhanced Prediction of HER2 Status in Breast Cancer through the Integration of Intratumoral and Peritumoral Radiomic Features from DCE-MRI

  • By

  • Yang Gao

  • Jiangnian Gong

  • Yuanling Yang

  • Yingyi Luo

  • Weiyi Liu

  • Zisan Zeng

  • February 13, 2026

  • 0 min

Share

Top Institutions in Radiology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Oncology
    • Radiology
    • Radiomics
    • Molecular Pathology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Cancer Research
    • Radiology
    • Computational Oncology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Breast Oncology
    • Radiology
    • Translational Research

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Radiology
    • Breast Cancer Research
    • Biomedical Engineering

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Breast Imaging
    • Radiomics
    • Oncology

Original Source(s)

Enhanced Prediction of HER2 Status in Breast Cancer through the Integration of Intratumoral and Peritumoral Radiomic Features from DCE-MRI

  • by Yang Gao, Jiangnian Gong, Yuanling Yang, Yingyi Luo, Weiyi Liu, Zisan Zeng

  • February 13, 2026

Related Content

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment

Deep-Motion-Net: GNN-based volumetric liver shape reconstruction from single-view 2D projections

Early prediction of immune checkpoint inhibitor-related pneumonitis in advanced non-small cell lung cancer based on primary tumor Delta-radiomics features